Details van artikel 152 van 426 gevonden artikelen
357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial
Titel:
357 GLS-010 (Zimberelimab), a novel fully human anti-PD-1 mAb in chinese patients with recurrent/metastatic cervical cancer: results from a multicenter, open-label, single-arm phase II trial
Auteur:
Wu, X. Xia, L. Zhou, Q. Zhu, J. Wang, K. Chen, J. Huang, Y. Kurb, G. Chang, B. Zhao, W. Wang, X. Yang, Y. Lin, Z. Luo, X. Lou, G. Wang, C. Wang, J. Meng, H.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A147
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 152 van 426 gevonden artikelen